Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Imesch

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 23, 2016
The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen-receptor-independent mannerEleftherios P Samartzis, Patrick Imesch, Anja Twiehaus, et al.
JMIR Formative Research|March 18, 2022
Examining the Influence on Perceptions of Endometriosis via Analysis of Social Media Posts: Cross-sectional StudyJulian Matthias Metzler, Dimitrios Rafail Kalaitzopoulos, Laurin Burla, et al.
International Journal of Molecular Sciences|September 17, 2013
ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomasEleftherios P Samartzis, Aurelia Noske, Konstantin J Dedes, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 6, 2021
Popularity of endocrine endometriosis drugs and limited alternatives in the present and foreseeable future: A survey among 1420 affected womenLaurin Burla, Dimitrios Rafail Kalaitzopoulos, Julian Matthias Metzler, et al.
International Journal of Oncology|August 3, 2007
The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cellsAndre Fedier, Konstantin J Dedes, Patrick Imesch, et al.
Plos One|January 15, 2014
The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancerEleftherios P Samartzis, Aurelia Noske, Alexander Meisel, et al.
Journal of Ovarian Research|April 20, 2013
Developmental potential of human oocytes matured in vitro followed by vitrification and activationPatrick Imesch, David Scheiner, Min Xie, et al.
Oncotarget|July 1, 2014
Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibitionEleftherios P Samartzis, Katrin Gutsche, Konstantin J Dedes, et al.
Journal of Gynecologic Oncology|July 23, 2013
Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasiaMathias K Fehr, Marc Baumann, Michael Mueller, et al.
Acta Neurologica Belgica|June 15, 2024
Investigating migraine phenotype and dynamics in women with endometriosis: an observational pilot studyGabriele Merki-Feld, Hanna Dietrich, Patrick Imesch, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 23, 2016
The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen-receptor-independent mannerEleftherios P Samartzis, Patrick Imesch, Anja Twiehaus, et al.
JMIR Formative Research|March 18, 2022
Examining the Influence on Perceptions of Endometriosis via Analysis of Social Media Posts: Cross-sectional StudyJulian Matthias Metzler, Dimitrios Rafail Kalaitzopoulos, Laurin Burla, et al.
International Journal of Molecular Sciences|September 17, 2013
ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomasEleftherios P Samartzis, Aurelia Noske, Konstantin J Dedes, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 6, 2021
Popularity of endocrine endometriosis drugs and limited alternatives in the present and foreseeable future: A survey among 1420 affected womenLaurin Burla, Dimitrios Rafail Kalaitzopoulos, Julian Matthias Metzler, et al.
International Journal of Oncology|August 3, 2007
The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cellsAndre Fedier, Konstantin J Dedes, Patrick Imesch, et al.
Plos One|January 15, 2014
The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancerEleftherios P Samartzis, Aurelia Noske, Alexander Meisel, et al.
Journal of Ovarian Research|April 20, 2013
Developmental potential of human oocytes matured in vitro followed by vitrification and activationPatrick Imesch, David Scheiner, Min Xie, et al.
Oncotarget|July 1, 2014
Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibitionEleftherios P Samartzis, Katrin Gutsche, Konstantin J Dedes, et al.
Journal of Gynecologic Oncology|July 23, 2013
Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasiaMathias K Fehr, Marc Baumann, Michael Mueller, et al.
Acta Neurologica Belgica|June 15, 2024
Investigating migraine phenotype and dynamics in women with endometriosis: an observational pilot studyGabriele Merki-Feld, Hanna Dietrich, Patrick Imesch, et al.
Pageof 7